Clinical Trial Update: Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study comparing nivolumab plus temozolomide versus temozolomide alone in newly diagnosed elderly patients with glioblastoma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• OPDIVO (nivolumab)
• Temodar (Temozolomide)

Snippet

Sponsor: University of Sydney | Conditions: Glioblastoma Multiforme | Phase 2 | Status: ACTIVE_NOT_RECRUITING